Half a mouse brain, grown from human cells: what scientists just did, and why
What happened
Scientists at Stanford University have created mice whose brains are roughly half human tissue by volume. Here is how. The team first genetically engineered mice to be born without a cerebral cortex or hippocampus, two important brain regions. That left an empty space inside the skull. They then grew human brain tissue in the laboratory. They did this by taking donated skin cells and reprogramming them into stem cells, which were coaxed into forming small clumps of brain tissue called organoids. Newborn mice were given several injections of these human cells into the empty space. Each injection contained about 100,000 human brain cells. In total, the mice lacked about 14 million mouse brain cells and ended up with about 4 million human ones. Three months after surgery, the human tissue had connected to the mouse's blood supply and almost entirely filled the cavity. Some human neurons had formed connections with mouse brain cells and even the spinal cord. The work was published in the journal Nature and reported on 16 September 2026. The team calls the animals "xenocortical" mice.
Why this matters
The reason for doing something this unusual comes down to a simple, frustrating problem: we cannot look inside a living human brain in the detail researchers need. Sergiu Pașca, the professor of psychiatry who led the research, put it bluntly. "We've been trying really hard as a community to find therapeutic solutions for these conditions, but the reality is that in psychiatry and neurology we've been left behind [by] every single branch of medicine and we have fewer therapeutics than, again, every single branch of medicine," he said. He added: "That could be because the human brain is very complex, but it's also because the human brain is inaccessible. To a large extent, our goal has been to make aspects of human brain development and function accessible for investigation." The practical promise is this. Scientists could take cells from a patient with a particular brain disorder, turn them into brain tissue in a dish, grow that tissue in a living animal, and then watch how the disorder develops in actual human tissue. They could also test whether a drug does anything. The conditions in the researchers' sights include schizophrenia, epilepsy, cerebral palsy, intellectual disability and rare forms of dementia. These are areas where progress has been slow and where families have very few options.
What the evidence actually says
It is worth being precise about what was and was not achieved, because headlines about half-human brains invite some wild ideas. The mice were not made cleverer. Tests showed the animals were not enhanced by the transplants. The mice look normal, but they are cautious on their feet and more forgetful than ordinary mice, because they are missing large amounts of their own brain. The transplants improved their shaky gait and their memory problems a little, but did not fix them. The human tissue was also not a human brain in miniature. The human neurons were not structured or wired up in the same way as in people. The tissue was immature, roughly equivalent to that found halfway through human pregnancy. The researchers did already get two useful results. They exposed some animals to five hours of low oxygen, which showed how vulnerable human nerve cells are to oxygen deprivation. That is directly relevant to cerebral palsy, which can be caused by oxygen loss during pregnancy and birth. They also found that the human tissue contained rare cells called von Economo neurons, which had previously only been seen in post-mortem examinations. These are among the first cells to die in frontotemporal dementia, a rare form of the disease. Pașca now hopes to study that in these mice. The ethics are genuinely contested, and the scientists do not pretend otherwise. Organoid research has raised concerns about whether such tissue could ever become conscious or feel pain, and about the welfare of the animals involved. Pașca said the work received extensive ethical oversight from the start. Emily Jackson, professor of law at the London School of Economics and chair of a recent report on neural organoids for the Nuffield Council on Bioethics, said that oversight must continue: "Animal welfare is a really important concern, and it will be necessary to closely monitor these animals in order to evaluate the impact on them." There is also scientific disagreement about how useful this will be. Professor Madeline Lancaster, a group leader at the MRC Laboratory of Molecular Biology in Cambridge, said the approach suits questions where a whole animal is needed, but added: "It's less clear to me how this will inform our understanding of human brain development since it is rather artificial, and not at all like how the brain develops naturally." She also noted the direction most of the field wants to go: "It's obviously ethically sensitive and there needs to be a very good reason to do this type of animal experimentation, which most scientific avenues do not require. The field is still aiming for fully in vitro solutions." In vitro means grown in a dish, with no animals involved. So: a real technical achievement, an open ethical question, and a genuine debate among experts about how much it will teach us.
What to know
Researchers at Stanford University, publishing in Nature on 16 September 2026, created mice whose brains are about half human tissue by volume. They engineered mice to be born without a cortex and hippocampus, then injected human brain organoids grown from reprogrammed skin cells. The aim is to study conditions such as schizophrenia, epilepsy, cerebral palsy, intellectual disability and rare dementias in living human tissue, and to test possible drugs. The mice were not enhanced. The human tissue was immature and not wired like a human brain. Early results showed how vulnerable human neurons are to low oxygen, and revealed rare von Economo neurons linked to frontotemporal dementia. The work has had ethical oversight, but bioethicists say animal welfare monitoring must continue, and some neuroscientists question how much it will reveal about normal brain development. This is early-stage research. No treatment for any of these conditions has come from it yet, and any that did would be many years away. Sources: The Guardian, "Scientists create mice with part-human brains", 16 September 2026, https://www.theguardian.com/science/2026/sep/16/mice-part-human-brains-research ; BBC News, "Part-human part-mouse brain developed in science breakthrough", 16 September 2026, https://www.bbc.co.uk/news/articles/c60m3k28j81mo ; Nuffield Council on Bioethics, report on neural organoids, https://www.nuffieldbioethics.org/ This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. If you or a family member live with any of the conditions mentioned, speak to your clinical team about current treatment options.
Related articles
The first study of the Nepal glacier collapse: what the science found
On 26 August 2026, a massive section of overhanging glacier and rock broke away from Langtang Lirung mountain, on the border between Nepal and Tibet. The piece…
Scientists worked out when black holes 'burp' - and it comes down to one number
Astronomers say they have solved a long-standing puzzle about black holes: when they "burp". Black holes have a reputation as cosmic plugholes that swallow eve…